FluoTech Biosciences Limited
FTB-731: Innovative Nano-Carriers for Label-Free Controlled Release in Cardiovascular Disease Treatment
We developed an inherently Fluorescent Metal-Organic Framework (MOF)-based nanocarrier technology to cater to acute thrombosis. This breakthrough nanotechnology offers an effective and targeted drug delivery system that is not only efficient for therapy but also but also cost-effective for diagnosis. Thus, FTB-731 is a cutting-edge design to address the challenges of modern drug delivery in a novel way.
Team member(s)
Dr Elhousseini Hilal Mohamed* (Postdoc (BME), City University of Hong Kong)
Miss Fu Ya Tian (PhD (BME, 2024), City University of Hong Kong)
Miss Fong Ching Yin (PhD (BME, 2026), City University of Hong Kong)
* Person-in-charge
(Info based on the team's application form)
Miss Fu Ya Tian (PhD (BME, 2024), City University of Hong Kong)
Miss Fong Ching Yin (PhD (BME, 2026), City University of Hong Kong)
* Person-in-charge
(Info based on the team's application form)